Maze Therapeutics, Inc. (MAZE)
43.52
+2.75
(+6.75%)
USD |
NASDAQ |
Jan 20, 14:50
Maze Therapeutics EPS Diluted (Quarterly): -0.6258 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -13.16 |
| LENZ Therapeutics, Inc. | -0.5851 |
| Liminatus Pharma, Inc. | -0.0675 |
| Oruka Therapeutics, Inc. | -0.6871 |
| MapLight Therapeutics, Inc. | -0.6484 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.09M |
| Total Expenses (Quarterly) | 30.09M |
| Enterprise Value | 1.602B |
| Earnings Yield | -5.18% |
| Normalized Earnings Yield | -5.134 |